To investigate the biological relevance of these three different classes of TYRP1 peptides, we tested 4 of each of the Shared, B16-F10-(AIRE)-Unique and B16-F10-(AIRE)-Longer class (Fig. 7G) as vaccines against parental B16-F10 tumours. This evidence concerns the gene TYRP1 and neoplasm.